Navigation Links
Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time
Date:7/28/2011

2 40% 9% PENTASA 130.3 118.8 10% 6% RESOLOR 2.5 - n/a <1% 319.1 252.0 27% 16% Regenerative Medicine DERMAGRAFT 2.0 - n/a <1% 2.0 - n/a <1% General products FOSRENOL 86.5 92.1 -6% 4% XAGRID 45.9 45.0 2% 2% CARBATROL 33.3 43.1 -23% 2% 165.7 180.2 -8% 8% Other product sales 47.7 54.8 -13% 2% Total SP product sales 1,292.8 1,092.6 18% 64% HGT ELAPRASE 231.3 200.6 15% 11% REPLAGAL 225.3 149.9 50% 11% VPRIV 122.3 34.5 254% 6% FIRAZYR 10.9 4.8 127% <1% Total HGT product sales 589.8 389.8 51% 29% Total product sales 1,882.6 1,482.4 27% 93% Royalties: 3TC and ZEFFIX 46.8 74.7 -37% 2% ADDERALL XR 43.7 68.3 -36% 2% FOSRENOL 20.5 11.1 85% 1% Other 26.0 23.9 9% 1% Total royalties 137.0 178.0 -23% 6% Other revenues 15.5 5.1 204% 1% Total Revenues 2,035.1 1,665.5 22% 100%

Unaudited results for the three months to June 30, 2011

Non GAAP reconciliation

US GAAP Adjustments Acquisitions Divestments, Amortization & reorganizations & asset integration & discontinued 3 months to, June 30, impairments activities operations 2011 (a) (b) (c) $M $M $M $M Total revenues 1,062.9 - - - Costs and expenses: Cost of product sales 143.7 - - (2.8) Research and development 176.9 - - - Selling, general and administrative 440.3 (36.7) - - Loss on sale of product rights 2.2 - - (2.2) Reorganization costs 7.5 - - (7.5) Integration and acquisition costs 9.0 - (9.0) - Depreciation - - - - Total operating expenses 779.6 (36.7) (9.0) (12.5) Operating income 283.3 36.7 9.0 12.5 Interest income 0.6 - - - Interest expense (9.9) - - - Total other expense, net (9.3) - - - Income before income taxes and equity in earnings of equity method investees 274.0 36.7 9.0 12.5 Income taxes (69.7) (3.9) (1.1) (2.4) Equity in earnings of equity method investees, net of tax 1.2 - - - Net income 205.5 32.8 7.9 10.1 Impact of convertible debt, net of tax 8.4 - - - Numerator for diluted EPS 213.9 32.8 7.9 10.1 Weighted average number of shares (millions) - diluted 595.
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. Neogen Reports 27% Increase in Quarterly Net Income
2. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
3. Microbix Has Best-Ever Quarterly Sales
4. Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
5. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
6. Shires Replenished Portfolio Drives Excellent Quarterly Performance
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
9. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
10. Abbott Declares 343rd Consecutive Quarterly Dividend
11. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Port Washington, NY (PRWEB) May 22, 2013 ... most comprehensive line of accessories for the mobile lifestyle, ... to charge, sync, protect, and manage multiple iPad devices ... design award and the 2012 Good Design award, MultiCharger-X ... utilize the iPad, wherever it is deployed. , ...
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... the 3rd Annual Disruptive Innovations to Advance Clinical Trials ... Copley Plaza Hotel in Boston, MA. , Disruptive ... Janssen Pharmaceuticals and more share bold approaches to reduce ... , “Disruptive innovation needs to be big, or ...
(Date:5/22/2013)... BUFFALO, N.Y. , May 22, 2013 /PRNewswire/ ... exclusive license for a patent pending novel genomic ... a molecular diagnostic test that could help in ... (NEPC) prostate cancer.  Neuroendocrine prostate ... adenocarcinoma (PCA) that can arise de novo, but ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013  Organogenesis ... medicine, presented new data generated in collaboration with a ... health economics consultancy) demonstrating the significant healthcare resource and ... leg ulcers (VLU) place upon the US healthcare system. ... reveal annual costs of up to $15 billion and ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4
... 25 Encision Inc. ("Encision") (OTC Bulletin Board: ECIA), ... is emerging as a standard of care in minimally-invasive ... Inc. ("Caldera") to represent Caldera,s line of products. ... stress urinary incontinence which is estimated to affect 15 ...
... Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ... in its U.K. clinical trial to evaluate the ... combination with gemcitabine (Gemzar(R)) in patients with advanced ... principal investigators are Dr. Johann de Bono of ...
... is a true super hero to Senator Katherine Laforge. With stakes higher ... energy crisis that threatens to enslave America to OPEC forever. The message ... that alternative energy can free us from OPEC and put an end to ... ...
Cached Biology Technology:Encision Enters Into Sales Representation Agreement With Caldera Medical 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 2Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 3Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 4Batman Teams with Senator Katherine Laforge to Help Free America from OPEC 5
(Date:5/22/2013)... (NLST) investigators also conclude that the 20 percent ... tomography (LDCT) versus chest X-ray (CXR) screening previously ... at experienced screening centers in the United States. ... with their patients about the benefits and risks ... in the New England Journal of Medicine ...
(Date:5/22/2013)... Harvard physicists have developed a novel technique that can ... a process that is one of the most important, ... described in a paper in Nature , post-doctoral ... Dr. Melanie Schnell of the Center for Free-Electron Laser ... relies on finely-tuned microwave fields to identify molecular variants ...
(Date:5/22/2013)... Md. (May 22, 2013)The omega 3 fatty acids in ... cardiovascular diseaseso much so that the American Heart Association ... a week, particularly fatty varieties rich in omega 3s. ... a mystery. In a new study, scientists led by ... on this phenomenon by providing evidence that fish oil ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... Electronic products pollute our environment with a number of ... the U.S. alone, an estimated 70% of heavy metals ... TVs getting bigger and cheaper every year, environmental costs ... new Tel Aviv University solution applies a discovery in ...
... scientists claim that a new method of testing ... rapid and non-invasively method of diagnosing degenerative disorders. ... Comparative Neurology , reveals that Magnetic Resonance Spectroscopy ... allowing earlier diagnosis. The diagnosis of ...
... the Entomological Society of America, will feature two plenary ... 12-15, 2010. Christopher Marley, an author and insect ... "insect-phobe" into an aficionado during a speech called "The ... CA in the late 1960,s, where he had a ...
Cached Biology News:'Greening' your flat screen TV 2Research heralds potential for early diagnosis of degenerative brain disorders 2Christopher Marley and James McWilliams to give plenary speeches at Entomology 2010 2
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... acid hybridization Preparation Reconstitution: one ... 50 mg ficoll and 50 ... ml of water yields a ... biology Density: 1.00 g/mL (20 ...
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
...
Biology Products: